Scinapsis Analytics Inc.: federal grants and contributions: 3 agreements; $1.4M value; 1 departments; 2 programs.
Assay record ASY-CA-1ROFF8A064 · Cite as: Assay Systems, “Scinapsis Analytics Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/scinapsis-analytics-inc/
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
BenchSci enables pre-clinical pharmaceutical research scientists to select experimental reagents and model systems based on the documented history of experiments. As history contains a very large number of documented experiments, a “search” can result in a huge number of results. Many factors play into every drug development experiment, making the selection between all options difficult. Today, BenchSci uses a simple historic popularity ranking and this project will replace this ranking with a new ranking that incorporates as many experimental design factors as possible enabled by an ML model.
Upon completion of this project, scientists in industry and academic institutions will be able use BenchSci to find numerous reagents (e.g. RNAi, Recombinant, CRISPR, Cell Line) that are most likely to work in their specific experiments. This will help to reduce experimental failure by providing users access to AI-assisted reagent selection.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.